title: [Management of clinical or biological abnormalities during therapeutic trials].
authors.forename: C
authors.initials: C
authors.lastname: Benichou
authors.forename: G
authors.initials: G
authors.lastname: Danan
authors.forename: P
authors.initials: P
authors.lastname: Vigeral
mesh_terms: D058186:Acute Kidney Injury / Q000139:chemically induced; D000380:Agranulocytosis / Q000139:chemically induced; D000740:Anemia / Q000139:chemically induced; D002986:Clinical Trials as Topic; D003625:Data Collection; D003875:Drug Eruptions / Q000209:etiology; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D000637:Transaminases / Q000097:blood
chemical_list: D000637:Transaminases
vernacular_title: Conduites à tenir devant l'apparition d'anomalies cliniques ou biologiques au cours d'un essai thérapeutique.